The Centers for Medicare and Medicaid Services released the CY 2024 final rule, keeping the bundling policy for diagnostic radiopharmaceuticals but remaining open to future discussions and changes, as SNMMI and stakeholders push for unbundling and legislative support via the FIND Act.
Medical Imaging Manufacturers Express Concern for Significant Payment Cuts to Care Providers Under Proposed Rule
MITA expressed concern for the payment cuts included in CMS’ proposed payment policies for the PFS and Part B Rules for calendar year 2023.Read More
MITA has submitted comments in response to the Centers for Medicare and Medicaid Services’ request for information on various aspects of the Medicare Advantage program.Read More
A radiologist will now provide direct or general supervision of intravenous contrast media administration and ensure compliance, per the American College of Radiology CT and MRI Accreditation Committees.Read More
The number of non-physician providers submitting Medicare claims increased from 523 in 2017 to 608 in 2019, per a recent study.Read More
Insurer Calculation of Qualified Payment Amount for Out of Network Care May Violate No Surprises Act
In possible violation of the No Surprises Act, insurance company QPA calculations likely include rates from primary care provider contracts.Read More